We compared the rates of symptomatic intracranial hemorrhage ( sICH ) and good outcomes for combination therapy patients in the CLEAR-ER trial to a matched cohort of rt-PA patients from the National Institute of Neurological Disorders and Stroke ( NINDS ) trial .